Furthermore, in GBM, the inhibited expression of genes involved in the CD4 T cell immune response, either by strengthening the negative regulation of their proliferation or by reducing MHC class II antigen processing/presentation, represents an intrinsic feature that discriminates primary vs secondary brain tumors showing exactly opposite characteristics. This evidence concerns the gene CD4 and brain neoplasm.